Tuesday, November 14

Gore Main Pavilion, Mercury Ballroom

Pavilion Opens   |   9:00 am 
  Lunch Symposium  


Together. Advancing Vascular Care.

Discover how recent developments are helping physicians make a difference in the lives of patients. This discussion, focused on how we partner with you to solve unique needs in complex cases, will feature insights, clinical findings, and case studies across the spectrum of vascular care; from aortic and carotid to peripheral and more.
Mark Farber, MD, Chapel Hill, North Carolina
Claudio Schönholz, MD, Charleston, South Carolina

Evening Event   |   6:00 pm  

Together. Improving Outcomes, Changing Lives.

Experience the treatment journeys of complex cases from the perspective of patients and their physicians. This evening features inspirational personal narratives, focusing on how our innovative vascular solutions and collaborative partnerships have impacted their treatments and their lives.

Wednesday, November 15

Gore Main Pavilion, Mercury Ballroom

 Pavilion Opens   |   6:00 am 
  Lunch Symposium  


Straight talk from the experts: Examining challenges and controversies in the treatment of complex peripheral disease

  • In the era of “leave nothing behind”, where do bare metal stents continue to play a critical role?
    Scott Berman, MD, Tucson, Arizona
  • Challenges in the treatment of IOD: Why not all balloon expandable stents are created equal
    Darren Schneider, MD, New York City, New York
  • Combating concerns for thrombosis: Strategies for optimal stent graft outcomes in long SFA lesions
    Darren Schneider, MD, New York City, New York
  • Gaining ground: Is the performance of prosthetic conduits getting closer to vein?
    Peter Lin, MD, Los Angeles, California
     

 Evening Event   |   6:00 pm 

Pavilion is in-use for invitation only event.

Thursday, November 16

Gore Main Pavilion, Mercury Ballroom

 Pavilion Opens   |   6:00 am 
  Lunch Symposium  

What are we learning as we evaluate the GORE® TAG® Thoracic Branch Endoprosthesis in a prospective clinical trial?
Dennis Gable, MD, Dallas, Texas

Evaluating the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System: What does early clinical experience tell us about this new device?
Giovanni Torsello, MD, Münster, Germany
 

 Evening Event   |   6:00 pm 

Pavilion is in-use for invitation only event.

Friday, November 17

GORE MAIN PAVILION, MERCURY BALLROOM

 Pavilion Opens   |   6:00 am 
  Lunch Symposium  

Insights from Latin America

Chairman: Pierre Galvagni, MD, Florianópolis, Brazil
Moderators: Bernardo Massiére, MD, Rio de Janeiro, Brazil
Bruno Freitas, MD, Maceió and Leipzig, Brazil and Germany

Endograft treatment demonstrates durable benefits in a 2-year RELINE Trial
Sidnei Galego, MD, São Paulo, Brazil

Clinical observations from Brazil: Evaluating the efficacy of GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface for endovascular treatment of popliteal aneurysms
Guilherme Napp, MD, Porto Alegre, Brazil

GORE® VIABAHN® Endoprosthesis demonstrates powerful patency in 20+ cm SFA Lesions
Marcio Miyamotto, MD, Curitiba, Brazil

GORE® VIABAHN® Endoprosthesis in treating stenosis or thrombotic occlusions of a synthetic arteriovenous (AV) access graft at the venous anastomosis
Antonio Henrique de Sousa Quintella, MD, Belo Horizonte, Brazil

    Saturday, November 18

    GORE MAIN PAVILION, MERCURY BALLROOM

     Pavilion Opens   |   6:00 am 
      Lunch Symposium  

    How unique dialysis access technologies help optimize patient outcomes

    • How early cannulation grafts assist with earlier removal of central venous catheters
      Matteo Tozzi, MD, Varese, Italy
    • Achieving long-term value: How stent grafts impact the treatment of the thrombosed dialysis graft
      Scott Berman, MD, Tucson, AZ
    • A novel approach to hemodialysis access: Using the GORE® Hybrid Vascular Graft in patients with limited access options
      Scott Berman, MD, Tucson, AZ